These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3725619)

  • 21. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z; Fischer R; Treadwell M; Yamashita R; Fung EB; Calvelli L; Quirolo K; Foote D; Harmatz P; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():486-91. PubMed ID: 16339703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ; Weatherall DJ
    Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    North ML; Lang JM; Bergerat JP; Giron C; Oberling F; Mayer S
    Nouv Rev Fr Hematol (1978); 1984; 26(5):317-21. PubMed ID: 6334273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
    De Virgiliis S; Cossu P; Sanna G; Frau F; Loi E; Lobrano R; Nucaro A; Toccafondi C; Cornacchia G; Loi A; Cao A
    Acta Haematol; 1982; 67(1):49-56. PubMed ID: 6800202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal serum ferritin levels following prolonged desferrioxamine therapy: Melbourne experience.
    Matthews RN
    Birth Defects Orig Artic Ser; 1988; 23(5B):117-22. PubMed ID: 3390533
    [No Abstract]   [Full Text] [Related]  

  • 30. Delayed decrease in serum ferritin in polytransfused children with thalassemia major after continuous subcutaneous infusions of desferrioxamine.
    Schettini F; Mautone A; Cavallo L; Altomare M; Montagna O; Dell'Edera L
    Acta Haematol; 1981; 66(2):96-101. PubMed ID: 6794319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations of ferritin levels over a period of 15 years as a compliance chelation index in thalassemic patients.
    Kattamis A; Dinopoulos A; Ladis V; Berdousi H; Kattamis C
    Am J Hematol; 2001 Dec; 68(4):221-4. PubMed ID: 11754409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desferrioxamine: its use in iron chelation in thalassemia.
    Sharma BK; Choudhury P; Dubey AP
    Indian Pediatr; 1990 Mar; 27(3):314-9. PubMed ID: 2190932
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thalassemia trait in the pediatric age and body iron status].
    Abreu de Miani MS; Calvo EB; Sanchís ME; Peñalver JA
    Sangre (Barc); 1986; 31(1):1-6. PubMed ID: 3704880
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to long-term deferoxamine therapy in thalassemia.
    Cohen A; Martin M; Schwartz E
    J Pediatr; 1981 Nov; 99(5):689-94. PubMed ID: 7299539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
    Kontopoulou-Griva I; Hatzidimitriou-Papazacharia K; Spiliotopoulou J; Tsagarakis N; Digenopoulou E
    Birth Defects Orig Artic Ser; 1988; 23(5B):111-6. PubMed ID: 3390532
    [No Abstract]   [Full Text] [Related]  

  • 36. Early iron overload in beta-thalassaemia major: when to start chelation therapy?
    Fargion S; Taddei MT; Gabutti V; Piga A; Di Palma A; Capra L; Fontanelli G; Avanzini A
    Arch Dis Child; 1982 Dec; 57(12):929-33. PubMed ID: 7181522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained normalization of cardiac function by chelation therapy in thalassaemia major.
    Freeman AP; Giles RW; Berdoukas VA; Talley PA; Murray IP
    Clin Lab Haematol; 1989; 11(4):299-307. PubMed ID: 2605872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine.
    Graziano JH; Markenson A; Miller DR; Chang H; Bestak M; Meyers P; Pisciotto P; Rifkind A
    J Pediatr; 1978 Apr; 92(4):648-52. PubMed ID: 633032
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in urinary iron in thalassemia major in relation to the administration of desferrioxamine].
    Esposito L; Ferrara M; Galdo Capotorti M
    Pediatria (Napoli); 1978 Mar; 86(1):69-76. PubMed ID: 683795
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of serum ferritin in the A2 and F thalassemic syndromes].
    Mira Y; Llopis R; Cubillo P; Vayá A; Aznar J
    Sangre (Barc); 1985; 30(6):965-70. PubMed ID: 2420016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.